Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Chubb
Covington
Medtronic
Cerilliant
Cantor Fitzgerald
Express Scripts
Cipla
Farmers Insurance

Generated: November 18, 2018

DrugPatentWatch Database Preview

Loxapine - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for loxapine and what is the scope of loxapine freedom to operate?

Loxapine is the generic ingredient in five branded drugs marketed by Galen Uk , Actavis Labs Ut Inc, Elite Labs Inc, Lannett Co Inc, Mylan, and Watson Labs, and is included in eleven NDAs. There are eighteen patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for loxapine. Two suppliers are listed for this compound.

Medical Subject Heading (MeSH) Categories for loxapine
Synonyms for loxapine
13-chloro-10-(4-methylpiperazin-1-yl)-2-oxa-9-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3,5,7,9,12,14-heptaene
13-chloro-10-(4-methylpiperazin-1-yl)-2-oxa-9-azatricyclo[9.4.0.0;{3,8}]pentadeca-1(11),3(8),4,6,9,12,14-heptaene
13-CHLORO-10-(4-METHYLPIPERAZIN-1-YL)-2-OXA-9-AZATRICYCLO[9.4.0.0(3),?]PENTADECA-1(15),3,5,7,9,11,13-HEPTAENE
1977-10-2
2-Chloro-11-(4-methyl-1-piperazinyl)-dibenz(b,f)(1,4)oxazepine
2-Chloro-11-(4-methyl-1-piperazinyl)dibenz(b,f)(1,4)oxazepine
2-Chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine
2-chloro-11-(4-methylpiperazin-1-yl)dibenzo[b,f][1,4]oxazepine
2-Chloro-11-(4-methylpiperazino)dibenz[b,f][1,4]oxazepine
2-Chloro-11-(4-methylpiperazino)dibenzo(b,f)(1,4)oxazepine
27833-64-3 (succinate)
3785AH
54810-23-0 (mono-hydrochloride)
8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzoxazepine
8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,5]benzoxazepine
8-chloro-6-(4-methylpiperazino)benzo[b][1,4]benzoxazepine;succinic acid
977L102
AB00053735_15
AB00053735_16
AC1L1H3Z
AC1Q3ZWR
Adasuve
Adasuve (TN)
AKOS030526111
API0006785
AZ-004
BDBM22871
BPBio1_000226
BRD-K39915878-036-04-6
BRD-K39915878-036-05-3
BRN 0626753
BSPBio_000204
BSPBio_003479
C07104
C18H18ClN3O
CCG-204805
CHEBI:50841
CHEMBL831
CL 62,362
CL 62362
CL-62362
CL-71,563
CL-71563
CL71,563
Cloxazepine
CS-1105
D02340
D0U5OE
DB00408
Dibenz(b,f)(1,4)oxazepine, 2-chloro-11-(4-methyl-1-piperazinyl)-
Dibenz[b,f][1,4]oxazepine, 2-chloro-11-(4-methyl-1-piperazinyl)-
Dibenzacepin
Dibenzoazepine
DivK1c_006919
DTXSID7023229
EINECS 217-835-3
GTPL205
HF 3170
HF3170
HSDB 3111
HY-17390
Hydrofluoride 3170
KBio1_001863
KBio2_000835
KBio2_003403
KBio2_005971
KBio3_002983
KBioSS_000835
L001085
LER583670J
Lopac0_000720
Lossapina
Lossapina [DCIT]
Loxapac
Loxapac (TN)
Loxapin
Loxapina
Loxapina [INN-Spanish]
Loxapine (USAN/INN)
Loxapine [USAN:BAN:INN]
Loxapine [USAN:INN:BAN]
Loxapinsuccinate
Loxapinum
Loxapinum [INN-Latin]
Loxepine
Loxipine Maleate
Loxitane
Loxitane (TN)
LOXITANE C
Loxitane IM
Loxitane Intramuscular
Loxitane-C Oral Suspension
LS-61562
LW 3170
NCGC00021145-01
NCGC00021145-02
NCGC00021145-03
NCGC00021145-04
NCGC00021145-05
NCGC00021145-06
NCGC00021145-07
NCGC00021145-08
NCGC00022279-03
NCGC00022279-04
NCGC00022279-05
Oxilapine
PDSP1_001058
PDSP2_001042
PL039237
Prestwick0_000132
Prestwick1_000132
Prestwick2_000132
Prestwick3_000132
QTL1_000050
S 805
S-805
SCHEMBL94146
SPBio_001814
SPBio_002143
SpecPlus_000823
Spectrum_000355
Spectrum2_001737
Spectrum3_001830
Spectrum5_001857
Staccato loxapine
SUM 3170
SUM-3170
UNII-LER583670J
W-5098
XJGVXQDUIWGIRW-UHFFFAOYSA-N
ZINC19796158

US Patents and Regulatory Information for loxapine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Galen Uk ADASUVE loxapine POWDER;INHALATION 022549-001 Dec 21, 2012 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Elite Labs Inc LOXAPINE SUCCINATE loxapine succinate CAPSULE;ORAL 076868-002 Aug 4, 2005 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Galen Uk ADASUVE loxapine POWDER;INHALATION 022549-001 Dec 21, 2012 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Actavis Labs Ut Inc LOXITANE loxapine succinate TABLET;ORAL 017525-006 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lannett Co Inc LOXAPINE SUCCINATE loxapine succinate CAPSULE;ORAL 090695-001 Sep 26, 2011 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lannett Co Inc LOXAPINE SUCCINATE loxapine succinate CAPSULE;ORAL 090695-003 Sep 26, 2011 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Galen Uk ADASUVE loxapine POWDER;INHALATION 022549-001 Dec 21, 2012 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for loxapine

Country Document Number Estimated Expiration
European Patent Office 1389094 ➤ Sign Up
Australia 2002303868 ➤ Sign Up
China 1304067 ➤ Sign Up
New Zealand 540208 ➤ Sign Up
World Intellectual Property Organization (WIPO) 02094229 ➤ Sign Up
Australia 2002310086 ➤ Sign Up
European Patent Office 1392242 ➤ Sign Up
Country Document Number Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for loxapine

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2013 00046 Denmark ➤ Sign Up PRODUCT NAME: LOXAPIN; REG. NO/DATE: EU/1/13/823/001-002 20130220
3 Finland ➤ Sign Up
2013 00046 Denmark ➤ Sign Up PRODUCT NAME: LOXAPIN; REG. NO/DATE: EU/1/13/823/001-002 20130220
90040-2 Sweden ➤ Sign Up PRODUCT NAME: LOXAPIN; REG. NO/DATE: EU/1/13/823/001 20130220
0609 Netherlands ➤ Sign Up PRODUCT NAME: LOXAPINE; REGISTRATION NO/DATE: EU/1/13/823/001-002 20130220
00609 Netherlands ➤ Sign Up PRODUCT NAME: LOXAPINE; REGISTRATION NO/DATE: EU/1/13/823/001-002 20130220
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Chubb
Covington
Medtronic
Cerilliant
Cantor Fitzgerald
Express Scripts
Cipla
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.